当前位置： SCI文献检索 > Human Vaccines & Immunotherapeutics期刊下所有文献 > Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.

Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.

Abstract：

:In the clinical trials of the quadrivalent human papillomavirus (qHPV) vaccine, antibodies were measured by a competitive Luminex immunoassay (HPV-4 cLIA). A nine-valent HPV (9vHPV) vaccine targeting the types in the qHPV vaccine (HPV6/11/16/18), as well as 5 of the next most frequent HPV types found in cervical cancers worldwide (HPV31/33/45/52/58) is under development. To support the 9vHPV vaccine program, a nine-multiplexed cLIA (HPV-9 cLIA) was developed. Antibody titers were determined in a competitive format, where type-specific phycoerythrin (PE)-labeled, neutralizing mAbs (mAbs-PE) compete with an individual's serum antibodies for binding to conformationally sensitive, neutralizing epitopes on the VLPs. Neutralizing antibody levels were quantitated against a reference standard - a pool of sera from 6 Rhesus macaques that were immunized with the 9vHPV vaccine. Specificity of the mAbs was assessed by measuring their individual binding capacities to the type-specific and non-type-specific VLPs at alternative concentrations of the mAbs. Antibody assignments to the HPV-9 cLIA reference standard for HPV6/11/16/18 were determined to provide for a measure of consistency in serostatus assignment between the HPV-4 and HPV-9 cLIAs. Antibody assignments to the HPV-9 reference standard for HPV31/33/45/52/58 were obtained by calibration to HPV11 using a direct binding IgG assay. For each HPV VLP type, the cross-reactivity of the mAb-PEs in the HPV-9 cLIA was <1% (i.e., the mAb-PEs result in <1% non-specific binding). The antibody concentrations assigned to the HPV-9 cLIA reference standard for types 6/11/16/18/31/33/45/52/58 were 3,817, 2,889, 23,061, 5,271, 3,942, 2,672, 1,489, 1274, and 2263 mMU/mL, respectively.

journal_name

Hum Vaccin Immunother

journal_title

Human vaccines & immunotherapeutics

authors

Roberts C,Green T,Hess E,Matys K,Brown MJ,Haupt RM,Luxembourg A,Vuocolo S,Saah A,Antonello J

doi

10.4161/hv.29205

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

2168-74

issue

8

eissn

2164-5515

issn

2164-554X

journal_volume

10

pub_type

杂志文章,评审

相关文献

Human Vaccines & Immunotherapeutics文献大全
  • ASVAC2019: 7th Asian Vaccine Conference.

    abstract：:The 7th Asian Vaccine Conference (ASVAC 2019) was held in Yangon, Myanmar from 13 to 15, September 2019. It brought together stakeholders in the field of vaccination to address challenges and issues relevant to clinical practice and immunization programs in the region. The conference themed "Immunization: sustaining h...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2019.1695460

    authors： Linn K,Bravo L,Goh DYT,Nelson EAS

    更新日期：2020-07-02 00:00:00

  • Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.

    abstract：:Japanese encephalitis (JE) is a serious public health concern in most of Asia. The disease is caused by JE virus (JEV), a flavivirus transmitted by Culex mosquitoes. Several vaccines have been developed to control JE in endemic areas as well as to protect travelers and military personnel who visit or are commissioned ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2017.1285472

    authors： Hegde NR,Gore MM

    更新日期：2017-06-03 00:00:00

  • Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.

    abstract：:The aim of this Phase IIIb, open-label, randomized study was to demonstrate the non-inferiority of immune responses and to assess the safety of a purified chick-embryo cell rabies vaccine (PCECV) in healthy Chinese children (6 to 17 years) and older adults (≥51 years) following 2 alternative intramuscular (IM) simulat...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.4161/21645515.2014.994460

    authors： Li R,Li Y,Wen S,Wen H,Nong Y,Mo Z,Xie F,Pellegrini M

    更新日期：2015-01-01 00:00:00

  • Novel nanoparticle vaccines for Listeriosis.

    abstract：:In recent years, nanomedicine has transformed many areas of traditional medicine, and enabled fresh insights into the prevention of previously difficult to treat diseases. An example of the transformative power of nanomedicine is a recent nano-vaccine against listeriosis, a serious bacterial infection affecting not on...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2015.1063756

    authors： Calderon-Gonzalez R,Marradi M,Garcia I,Petrovsky N,Alvarez-Dominguez C

    更新日期：2015-01-01 00:00:00

  • Completeness and timeliness of vaccination and determinants for low and late uptake among young children in eastern China.

    abstract：BACKGROUND:We studied completeness and timeliness of vaccination and determinants for low and delayed uptake in children born between 2008 and 2009 in Zhejiang province in eastern China. METHODS:We used data from a cross-sectional cluster survey conducted in 2011, which included 1146 children born from 1 Jan 2008 to 3...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.28054

    authors： Hu Y,Chen Y,Guo J,Tang X,Shen L

    更新日期：2014-01-01 00:00:00

  • Need to take special care of non-responders to hepatitis B vaccination among health-care workers, students and chronic patients.

    abstract：:Both our research and that published by Sticchi et al. on immunological memory against hepatitis B virus (HBV) in health-care workers (HCWs) vaccinated as infants or adolescents confirm that in those testing negative after the primary course, one additional (fourth) booster dose is able to elicit an anti-HBs response ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1810495

    authors： Bechini A,Bonanni P,Grazzini M,Paolini D,Arcangeli G,Mucci N,Bini C,Tiscione E,Zanella B,Boccalini S

    更新日期：2020-12-03 00:00:00

  • Vaccination among Polish university students. Knowledge, beliefs and anti-vaccination attitudes.

    abstract：:Anti-vaccination movement has existed as long as the vaccines themselves, but its mode of action and social influences evolved over time. Such attitude with no doubt has negative impact on vaccination rates and eradication of infectious diseases. In this study, we used an online survey to examine vaccination attitudes...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1365994

    authors： Zarobkiewicz MK,Zimecka A,Zuzak T,Cieślak D,Roliński J,Grywalska E

    更新日期：2017-11-02 00:00:00

  • Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran.

    abstract：:Eight months after the mass immunization campaign of November 2015 against measles and rubella in the southeast of Iran, in order to evaluate the sero-immunity level of the people living in the mentioned region, a serosurvey study was performed. Using a multi-stage probability proportional to size cluster sampling, th...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2018.1436920

    authors： Izadi S,Zahraei SM,Mokhtari-Azad T

    更新日期：2018-06-03 00:00:00

  • Correlates of protection to influenza virus, where do we go from here?

    abstract：:Influenza vaccination is the cornerstone of prophylaxis. The regulatory authorities currently annually license vaccines based on serum antibodies directed toward the major surface glycoprotein haemagglutinin (HA). The most commonly used serological test, the haemagglutination inhibition (HI) assay utilizes red blood c...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.22908

    authors： Cox RJ

    更新日期：2013-02-01 00:00:00

  • Approaches to the vaccination of pregnant women: experience from Stockport, UK, with prenatal influenza.

    abstract：:For the 2010/11 influenza season the prenatal vaccination program was extended to all women in England and Wales irrespective of gestational age--this was a considerable shift in practice for both pregnant women and healthcare providers where the emphasis previously had been only on targeted vaccination for pregnant w...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.25525

    authors： Baxter D

    更新日期：2013-06-01 00:00:00

  • Polio vaccination campaign in Pakistan: a step towards eradication or still a challenge in hand?

    abstract：:Polio is an acute viral disease that is still endemic in Pakistan. The polio vaccination program is facing many challenges that result in an increased number of new cases. The success of polio vaccination has been threatened in different parts of Pakistan. In the past, the immunization program was affected by differen...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1717152

    authors： Ahmad T,Khan M,Musa TH,Hui J

    更新日期：2020-06-02 00:00:00

  • Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.

    abstract：:Cancer progression depends on stepwise accumulation of oncogenic mutations and a select group of growth factors essential for tumor growth, metastasis and angiogenesis. Agents blocking the epidermal growth factor receptor (EGFR, also called HER1 and ERBB1) and the co-receptor called HER2/ERBB2 have been approved over ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2015.1102809

    authors： Gaborit N,Lindzen M,Yarden Y

    更新日期：2016-03-03 00:00:00

  • Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project.

    abstract：:The ESCULAPIO Project aims at increasing awareness on vaccine preventable infectious diseases (VPID) and vaccinations in different target populations and to spread the culture of prevention. Information/training interventions on VPID have been developed and health promotion activities for the general population, stude...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1268008

    authors： Bechini A,Bonanni P,Lauri S,Tiscione E,Levi M,Prato R,Fortunato F,Martinelli D,Gasparini R,Panatto D,Amicizia D,Coppola RC,Pellizzari B,Tabacchi G,Costantino C,Vitale F,Iannazzo S,Boccalini S

    更新日期：2017-02-01 00:00:00

  • Staphylococcus aureus and Streptococcus pneumoniae interaction and response to pneumococcal vaccination: Myth or reality?

    abstract：:S. aureus and S. pneumoniae are both common pathogens that are also carried by a large proportion of healthy individuals in the nasal and nasopharyngeal spaces. A negative association between carriage of S. aureus and S. pneumoniae has been reported in children in various epidemiologic studies from different geographi...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2015.1081321

    authors： Reiss-Mandel A,Regev-Yochay G

    更新日期：2016-01-01 00:00:00

  • Immunogenicity, reactogenicity and safety of a human rotavirus vaccine (RIX4414) in Korean infants: a randomized, double-blind, placebo-controlled, phase IV study.

    abstract：:Rotavirus (RV) infection is the primary cause for childhood gastroenteritis worldwide. In Korea, RV infection is most common among children less than 5 years of age. This post-licensure study was conducted to further evaluate the RV vaccine (RIX4414) to provide additional local clinical data to the Korean Food and Dru...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.4161/hv.19853

    authors： Kim JS,Bae CW,Lee KY,Park MS,Choi YY,Kim KN,Kim JD,Park WS,Sin JB,Kim EA,Lee SG,Kim CS,Cha SH,Hong YJ,Shin SM,Shim GH,Choi KM,Yang JW,Liu A,Suryakiran PV,Han HH

    更新日期：2012-06-01 00:00:00

  • Ebola vaccines in clinical trial: The promising candidates.

    abstract：:Ebola virus disease (EVD) has become a great threat to humans across the world in recent years. The 2014 Ebola epidemic in West Africa caused numerous deaths and attracted worldwide attentions. Since no specific drugs and treatments against EVD was available, vaccination was considered as the most promising and effect...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2016.1225637

    authors： Wang Y,Li J,Hu Y,Liang Q,Wei M,Zhu F

    更新日期：2017-01-02 00:00:00

  • Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial.

    abstract：:As a stepping stone toward evaluation in infants, the safety and immunogenicity of an investigational 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (12vPHiD-CV) was assessed in toddlers. 12vPHiD-CV contains CRM197-conjugated capsular polysaccharides of serotypes 6A and 19A in a...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1810493

    authors： Horn M,Behre U,Traskine M,Dobbelaere K,Borys D

    更新日期：2020-11-11 00:00:00

  • Malaria vaccine: a step toward elimination.

    abstract：:Malaria has long been recognized as a public health problem. At the community level, vector control, and antimalarial medicines are the main means for reducing incidence, morbidity, and mortality of malaria. A vaccine not only would bring streamlining in the prevention of morbidity and mortality from malaria but also ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.28482

    authors： Jindal H,Bhatt B,Malik JS,Sk S,Mehta B

    更新日期：2014-01-01 00:00:00

  • Maternal and infant outcomes among women vaccinated against pertussis during pregnancy.

    abstract：:Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination is recommended for all women during each pregnancy to prevent pertussis in young infants. However, data on the safety of this protective measure are limited and conflicting. To assess maternal and infant outcomes associated with administration of this vac...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2016.1157241

    authors： Berenson AB,Hirth JM,Rahman M,Laz TH,Rupp RE,Sarpong KO

    更新日期：2016-08-02 00:00:00

  • On-label and off-label use of high-dose influenza vaccine in the United States, 2010-2012.

    abstract：:High-dose inactivated, influenza vaccine was licensed by the FDA in December 2009 for adults aged 65 y and older. The ACIP did not issue or state a preference for a specific vaccine in the elderly population. The extent of its on-label and off-label use is unknown. Using the MarketScan Commercial Claims and Encounters...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2015.1011026

    authors： McGrath LJ,Brookhart MA

    更新日期：2015-01-01 00:00:00

  • Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.

    abstract：:Despite the impressive impact of vaccines on public health, the success of vaccines targeting many important pathogens and cancers has to date been limited. The burden of infectious diseases today is mainly caused by antigenically variable pathogens (AVPs), which escape immune responses induced by prior infection or v...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2016.1191718

    authors： Servín-Blanco R,Zamora-Alvarado R,Gevorkian G,Manoutcharian K

    更新日期：2016-10-02 00:00:00

  • Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel.

    abstract：BACKGROUND:Community acquired pneumonia (CAP) is a major cause of morbidity and mortality worldwide, and is a leading cause of hospitalization in previously healthy individuals without predisposing risk factors or comorbidities. In this study we determined PCV13 serotype distribution in adults aged ≥50 years with radio...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2018.1475811

    authors： Regev-Yochay G,Chowers M,Chazan B,Gonzalez E,Gray S,Zhang Z,Pride M

    更新日期：2018-01-01 00:00:00

  • Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis.

    abstract：:Background: Rotavirus (RV) is worldwide an important cause of acute gastroenteritis (AGE) in infants and young children. There is no specific treatment for AGE caused by RV (RVGE) but since 2006 two safe and effective vaccines have been available. RV vaccination was included in the national immunization program (NIP) ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2018.1534515

    authors： Tafalla M,Gardovska D,Gopala K,Kozlovska L

    更新日期：2019-01-01 00:00:00

  • A monoclonal antibody to an abrin chimera recognizing a unique epitope on abrin A chain confers protection from abrin-induced lethality.

    abstract：:Abrin, obtained from the seeds of Abrus precatorius plant, is a potent toxin belonging to the family of type II ribosome-inactivating proteins. Recently, a recombinant vaccine consisting of the A subunits of abrin and its homolog Abrus precatorius agglutinin (APA) was demonstrated to protect mice from abrin lethality....

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2015.1067741

    authors： Kumar MS,Karande AA

    更新日期：2016-01-01 00:00:00

  • Harnessing benefit from targeting tumor associated carbohydrate antigens.

    abstract：:Integrating additive or synergistic antitumor effects that focus on distinct elements of tumor biology are the most rational strategies for cancer treatment. Treatments for breast cancer have increased overall survival, but remain limited by lack of efficacy in a subset of breast cancer patients. The real challenge is...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2017.1264789

    authors： Kieber-Emmons T,Monzavi-Karbassi B,Hutchins LF,Pennisi A,Makhoul I

    更新日期：2017-02-01 00:00:00

  • Understanding motivators and barriers of hospital-based obstetric and pediatric health care worker influenza vaccination programs in Australia.

    abstract：:Understanding motivators and barriers of health care worker (HCW) vaccination programs is important for determining strategies to improve uptake. The aim of this study was to explore key drivers and HCW decision making related to recommended vaccines and seasonal influenza vaccination programs. We used a qualitative a...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2016.1153204

    authors： Tuckerman JL,Shrestha L,Collins JE,Marshall HS

    更新日期：2016-07-02 00:00:00

  • Incomplete vaccination and associated factors among children aged 12-23 months in South Africa: an analysis of the South African demographic and health survey 2016.

    abstract：BACKGROUND:Socioeconomic and health inequalities remain a huge problem in post-apartheid South Africa. Despite substantial efforts at ensuring universal access to vaccines, many children remain under-vaccinated in the country. This study aimed to assess the prevalence and factors associated with incomplete vaccination ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1791509

    authors： Ndwandwe D,Nnaji CA,Mashunye T,Uthman OA,Wiysonge CS

    更新日期：2020-07-23 00:00:00

  • Immunization services offered in Québec (Canada) pharmacies.

    abstract：:Canadian Pharmacists are easy to reach. Although Québec pharmacists are not allowed to administer vaccines, they can: (1) promote vaccination, (2) counsel patients on vaccination, (3) sell vaccines and (4) provide vaccine administration by a nurse. Our objectives were to describe immunization services given in Québec ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.25186

    authors： Sauvageau C,Dubé E,Bradet R,Mondor M,Lavoie F,Moisan J

    更新日期：2013-09-01 00:00:00

  • Influenza immunization during pregnancy: Benefits for mother and infant.

    abstract：:The serious consequences of influenza infection during pregnancy have been recognized for almost a century. In this article, we reviewed the evidence on the immunogenicity, safety and impact of maternal influenza immunization for both mother and child. After vaccination, pregnant women have similar protective titers o...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2016.1215392

    authors： Sakala IG,Honda-Okubo Y,Fung J,Petrovsky N

    更新日期：2016-12-01 00:00:00

  • Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults.

    abstract：:Individuals infected with human immunodeficiency virus (HIV) have excess risk of developing human papillomavirus (HPV)-related disease. A substantial fraction of HPV-associated cancers is caused by HPV serotypes not included in the currently available vaccines. Among healthy women, both Cervarix(®) (HPV-16/18, GlaxoSm...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.4161/hv.27925

    authors： Toft L,Tolstrup M,Müller M,Sehr P,Bonde J,Storgaard M,Østergaard L,Søgaard OS

    更新日期：2014-01-01 00:00:00